Key result
Treatment may produce objective improvement in ischaemic necrosis and symptomatic benefit in patients with persistent cold feet, but has no effect on intermittent claudication.
Why the study?
Does anticoagulant therapy reduce mortality and thrombo-embolic episodes in hospitalized patients with acute myocardial infarction?
Does anticoagulant therapy reduce mortality and thrombo-embolic episodes in hospitalized patients with acute myocardial infarction?
Early and efficient use of anticoagulants in acute myocardial infarction significantly reduces the six-week mortality rate and the incidence of thrombo-embolic complications.
May support targeted symptom relief in necrosis or cold feet; leaves open claudication efficacy pending randomized trials.
PERIPHERAL VASCULAR DISEASE "I BRrr= 100 mg. may be given at weekly intervals.The treatment may produce objective improvement in ischaemic necrosis and symptomatic benefit in patients with persistent cold feet, but has no effect on intermittent claudication.Many patients with symptoms primarily referable to the skin will improve after sympathectomy, but the selection of suitable cases in the elderly grows more difficult with increasing age.
No takes yet. Share an insight, caveat, or question.
Annette Gilchrist (1954) conducted a review in Peripheral vascular disease. Treatment (I BRrr) was evaluated. Treatment may produce objective improvement in ischaemic necrosis and symptomatic benefit in patients with persistent cold feet, but has no effect on intermittent claudication.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: